Portfolio company
Neumarker
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence software providing brain biomarkers to support clinical decisions and central nervous system drug development for hospitals and pharmaceutical firms.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neurophet
This company develops artificial intelligence software for brain image analysis and stimulation planning for clinicians, medical institutions and pharmaceutical researchers.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
RebrAIn
The company develops artificial intelligence software to help neurosurgeons identify optimal brain targets for deep brain stimulation and lesioning treatments.
Neuronostics
The company develops an EEG-based digital biomarker platform to provide objective diagnostic and prognostic support for epilepsy to healthcare providers and pharmaceutical researchers.
BrainsightAl
This company develops artificial intelligence software for functional brain mapping to assist clinicians with neurological and psychiatric diagnosis and neurosurgical planning.
Hemispheric
This company develops artificial intelligence models and platforms for decoding non-invasive brain signals to assist clinicians and researchers with neurological and psychiatric diagnoses.
BrainQuant
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
Brainify.AI
This company develops EEG-based artificial intelligence platforms and biomarkers for pharmaceutical companies and longevity centres to improve clinical trials and patient care.
